IMMUNOBLOT REACTIVITIES OF DIFFERENT LYME DISEASE SPECIFIC ANTIGENS TO ANTI-BORRELIA BURGDORFERI IgG ANTIBODIES
DOI:
https://doi.org/10.58395/zv4zm832Keywords:
Lyme disease, immunoblot, antibodiesAbstract
Background: Lyme disease is a vector-borne disease with increasing incidences in last years. It is the most common tick-borne infection in Bulgaria, caused by Borrelia burgdorferi sensu lato (Bbsl) complex after a bite from Ixodes ricinus tick. The aim of this study is to identify the most common antigens targeted by specific IgG antibodies produced in response toBbsl infection in humans.
Material and methods: Serum samples (n=220), pre-tested as positive or borderline by ELISA for specific anti-Borrelia IgG antibodies, were tested with a commercially available confirmatory immunoblot kit.
Results: The most common specific anti-Borrelia IgG antibodies reacted against: p41 (97.1%), VlsE (average of 62.1% across the three variants: VlsE Bg, VlsE Bb and VlsE Ba), p83 (32.4%), p39 (30.4%) and OspC (22.6%) among the positively interpreted immunoblot tests. The weak positive bands among the positively interpreted blot tests were: OspC (17.7%), VlsE (average of 10.5% across the three variants), p21 (9.8%), p39 (8.8%), p83 (6.9%).
Conclusions: This study analysed the most common antigens targeted by specific IgG antibodies synthesised after Bbsl infection in humans from all 28 provinces of Bulgaria. It was probably cross-reactive antibodies that appeared in some cases with weak positive bands. The data obtained from the confirmed cases of Lyme disease, based on the different distribution of immunoblot bands allow for a better understanding the peculiarities of this disease. The use of new specific antigens for confirmatory tests based on selected conserved fragments within Bbsl leads to development of more sensitive and specific serological analysеs.
Downloads
References
1. European Centre for Disease Prevention and Control. Factsheet about Borreliosis. Available online: https://www.ecdc.europa. eu/en/borreliosis/facts/factsheet (accessed on 18 December 2024)
2. Grazlewska, W, Holec-Gasior, L. Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease. Antibodies, 2023, 12, 63. https://doi.org/10.3390/antib12040063
3. Lohr B, Fingerle V, Norris DE, Hunfeld K-P. Laboratory diagnosis of Lyme borreliosis: Current state of the art and future perspectives. Crit. Rev. Clin. Lab. Sci. 2018, 55, 219–245. https://doi.org/10.1080/10408363.2018.1450353
4. Ohnishi J, Piesman J, de Silva AM. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc. Natl. Acad. Sci. USA 2001, 98, 670–675. https://doi.org/10.1073/pnas.98.2.670
5. Jonsson M, Noppa L, Barbour AG, Bergstrom S. Heterogeneity of outer membrane pr oteins in Borrelia burgdorferi: Comparison of osp operons of three isolates of different geographic origins. Infect. Immun. 1992, 60, 1845–1853. https://doi.org/10.1128/iai.60.5.1845-1853.1992
6. Roberts WC., Mullikin BA, Lathigra R, Hanson MS. Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato. Infect. Immun. 1998, 66, 5275–5285. https://doi.org/10.1128/iai.66.11.5275-5285.1998
7. Centers for disease control and prevention (CDC) recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease. JAMA J. Am. Med. Assoc. 1995, 274, 937. https://doi.org/10.1001/jama.1995.03530120023018
8. Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a vlse c6 peptide enzyme immunoassay. Clin. Infect. Dis. 2011, 53, 541–547. https://doi.org/10.1093/cid/cir464
9. Liu Song, Iris Du Cruz, Catherine Calalo Ramos, Paula Taleon, Ranjan Ramasamy, Jyotsna Shah. Pilot Study of Immunoblots with Recombinant Borrelia burgdorferi Antigens for Laboratory Diagnosis of Lyme Disease. Healthcare (Basel), 2018 Aug 14,6(3):99. https://doi.org/10.3390/healthcare6030099.
10. Porwancher Richard, Andrew Levin, Rosalie Trevejo. Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches Pathogens, 2023 Oct 26,12 (11):1282. https://doi.org/10.3390/pathogens12111282.
11. Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR. Morb. Mortal. Wkly. Rep. 2019, 68, 703. https://www.cdc.gov/mmwr/volumes/68/wr/mm6832a4.htm?s_cid=mm6832a4_w (accessed on 20 December 2024)
12. Luft BJ, Dunn JJ, Dattwyler RJ, Gorgone G, Gorevic PD, Schubach WH. Cross-reactive antigenic domains of the flagellin protein of Borrelia burgdorferi. Res. Microbiol. 1993, 144, 251–257. https://doi.org/10.1016/0923-2508(93)90009-Q
13. Magnarelli LA, Miller JN, Anderson JF, Riviere GR. Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease. J. Clin. Microbiol. 1990, 28, 1276–1279. https://doi.org/10.1128/jcm.28.6.1276-1279.1990
14. Patriquin G, LeBlanc J, Heinstein C, Roberts C, Lindsay R, Hatchette TF. Cross-reactivity between Lyme and syphilis screening assays: Lyme disease does not cause false-positive syphilis screens. Diagn. Microbiol. Infect. Dis. 2016, 84, 184–186. https://doi.org/10.1016/j.diagmicrobio.2015.11.019
15. Rawlins ML, Gerstner C, Hill HR, Litwin CM. Evaluation of a Western blot method for the detection of Yersinia antibodies: Evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi. Clin. Diagn. Lab. Immunol. 2005, 12, 1269–1274. https://doi.org/10.1128/CDLI.12.11.1269-1274.2005
16. Golkocheva-Markova E, Nenova R, Stoilov R, Christova I, Najdenski H. Cross-reactivity between Yersinia outer membrane proteins and anti-Francisella and anti-Borrelia antibodies in serodiagnosis of Yersinia-triggered reactive arthritis. Comptes Rendus L’Academie Bulg. Sci. 2011, 64, 61–66.
17. Golkocheva-Markova E, Christova I, Stoilov R, Najdenski H. Cross-reaction between Yersinia outer membrane proteins and anti- Borrelia antibodies in sera of patients with Lyme disease. Clin. Microbiol. Infect. 2008, 14, 873–875. https://doi.org/10.1111/j.1469-0691.2008.02051.x
18. Mahajan Vikram K. Lyme Disease: An Overview. Indian Dermatol Online J. 2023 Feb 23,14(5):594-604. https://doi.org/10.4103/idoj.idoj_418_22
19. Kalish R, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin. Infect. Dis. 2001, 33, 780–785. https://doi.org/10.1086/322669
20. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol. 2007, 49, 13–21. https://doi.org/10.1111/j.1574-695X.2006.00139.x
21. Ma B, Christen B, Leung D, Vigo-Pelfrey C. Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J. Clin. Microbiol. 1992 Feb,30(2):370–376. https://doi.org/10.1128/jcm.30.2.370-376.1992
22. Wojciechowska-Koszko I, Kwiatkowski P, Sienkiewicz M, Kowalczyk M, Kowalczyk E, Dołegowska B. Cross-reactive results in serological tests for borreliosis in patients with active viral infections. Pathogens 2022, 11, 203. https://doi.org/10.3390/pathogens11020203
23. Smismans A, Goossens VJ, Nulens E, Bruggeman CA. Comparison of five different immunoassays for the detection of Borrelia burgdorferi IgM and IgG antibodies. Clin. Microbiol. Infect. 2006, 12, 648–655. https://doi.org/10.1111/j.1469-0691.2006.01448.x
24. Talagrand-Reboul E, Raffetin A, Zachary P, Jaulhac B, Eldin C. Immunoserological diagnosis of human borrelioses: Current knowledge and perspectives. Front. Cell. Infect. Microbiol. 2020, 10, 241. https://doi.org/10.1128/iai.00828-15
25. Magnarelli LA, Lawrenz M, Fikrig E, Norris SJ. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J. Med. Microbiol. 2002, 51, 649–655. https://doi.org/10.1099/0022-1317-51-8-649
26. Panelius J, Lahdenne P, Heikkila T, Peltomaa M, Oksi J, Seppala I. Recombinant OspC from Borrelia burgdorferi sensu stricto B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. J. Med. Microbiol. 2002, 51, 731–739. https://doi.org/10.1099/0022-1317-51-9-731
27. Magnarelli LA, Ijdo JW, Padula SJ, Flavell RA, Fikrig E. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. J. Clin. Microbiol. 2000, 38, 1735–1739. https://doi.org/10.1128/jcm.38.5.1735-1739.2000
28. Tjernberg I, Krüger G, Eliasson I. C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden. Eur. J. Clin. Microbiol. Infect. Dis. 2007, 26, 37–42. https://doi.org/10.1007/s10096-006-0239-3
29. Engstrom SM , Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol. 1995 Feb,33(2):419-27. https://doi.org/10.1128/jcm.33.2.419-427.1995
30. Branda John A, Allen C Steere. Laboratory Diagnosis of Lyme Borreliosis. Clin. Microbiol. Rev. 2021 Jan 27,34(2): e00018-19. https://doi.org/10.1128/CMR.00018-19
31. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 2010, 20, 202–213. https://doi.org/10.1002/rmv.655
32. Shah Jyotsna S, Joseph J Burrascano, Ranjan Ramasamy. Recombinant protein immunoblots for differential diagnosis of tick-borne relapsing fever and Lyme disease. J. Vector Borne Dis. 60, December 2023, pp. 353–364. https://doi.org/10.4103/0972-9062.383641
33. Brisson Dustin, Dan Drecktrah, Christian H Eggers, D Scott Samuels, Genetics of Borrelia burgdorferi. Annu. Rev. Genet. 2012, 46: 515-36. https://doi.org/10.1146/annurev-genet-011112-112140
34. Lawrenz MB, Hardham JM, Owens RT, Nowakowski J, Steere AC, Wormser GP, Norris SJ. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 1999 Dec, 37(12):3997-4004. https://doi.org/10.1128/JCM.37.12.3997-4004.1999
35. Chanrda Abhishek, Norman Latov, Gary P Wormser, Adriana R Marques, Armin Alaedini. Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome. J. Clin. Immunol. 2011 Oct,141(1):103-10. https://doi.org/10.1016/j.clim.2011.06.005
36. Rogovskyy Artem S, Timothy Casselli, Yvonne Tourand, Cami R Jones, Jeb P Owen, Kathleen L Mason, Glen A Scoles, Troy Bankhead. Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi. PLoS One. 2015 Apr 20,10(4): e0124268. https://doi.org/10.1371/journal.pone.0124268
37. Wilske B. Diagnosis of Lyme borreliosis in Europe. Vector-Borne Zoonotic Dis. 2003,3:215–227. https://doi.org/10.1089/153036603322662200
38. Bušová Andrea, Erik Dorko, Kvetoslava Rimárová, Jana Diabelková, Tíme Rovenská, Eva Feketeová, Matúš Bereš, Róbert Čellár, Zuzana Baranová, Tomáš Kampe, Karim Benhatchi. Seroprevalence of Lyme disease in Eastern Slovakia. Cent Eur J Public Health. 2018 Dec: 26 Suppl: S67-S71. https://doi.org/10.21101/cejph.a5442
39. Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowsk J, Marques A, Johnson BJB, Dumler JS. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn. Microbiol. Infect. Dis. 2013, 75, 9–15. https://doi.org/10.1016/j.diagmicrobio.2012.09.003
40. Glatz M, Fingerle V, Wilske B, Ambros-Rudolph C, Kerl H, Müllegger RR. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans. Dermatology 2008, 216, 93–103. https://doi.org/10.1159/000111505
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Teodora Gladnishka, Iva Trifonova, Kim Ngoc, Vladislava Ivanova, Elitsa Panayotova, Evgenia Taseva, Iva Christova (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
